{"schemaVersion":"ready-scan.discovery-entity.v3","id":"urn:readyscan:entity:symaptics-q140724419","slug":"symaptics-q140724419","kind":"entity","entityType":"Organization","canonicalUrl":"https://directory.readyscan.ai/entities/symaptics-q140724419","machineUrl":"https://directory.readyscan.ai/discovery/entities/symaptics-q140724419.json","llmsUrl":"https://directory.readyscan.ai/entities/symaptics-q140724419/llms.txt","name":"Symaptics","alternateNames":[],"websiteUrl":"https://symaptics.com/","category":{"slug":"businesses","name":"Businesses","canonicalUrl":"https://directory.readyscan.ai/directory/businesses"},"description":"Symaptics: “Symaptics builds SyMAP, a pharmaceutical pricing and market access platform covering international reference pricing simulation, US Most Favored Nation policy modelling, and global revenue forecasting and optimisation. London based, founded by pharmaceutical pricing specialists.”","summary":"Symaptics: “Symaptics builds SyMAP, a pharmaceutical pricing and market access platform covering international reference pricing simulation, US Most Favored Nation policy modelling, and global revenue forecasting and optimisation. London based, founded by pharmaceutical pricing specialists.”","localizedDescriptions":[],"claims":[{"id":"content-native-digital-agencies-12f6a9202d9259db-a-603be0e3bf5c7b2a558f","label":"Symaptics","value":"“Symaptics builds SyMAP, a pharmaceutical pricing and market access platform covering international reference pricing simulation, US Most Favored Nation policy modelling, and global revenue forecasting and optimisation. London based, founded by pharmaceutical pricing specialists.”","sourceIds":["source-record"]},{"id":"content-native-digital-agencies-12f6a9202d9259db-a-4b975b07e2a09adeb35e","label":"Do we need a SyMAP licence?","value":"“No. You can commission a project on its own. A licence is optional if you want your team to edit and rerun models afterwards.”","sourceIds":["source-51046b84b97e8abe"]},{"id":"content-native-digital-agencies-12f6a9202d9259db-a-4b162458202451775303","label":"How long does a project take?","value":"“Timing depends on the portfolio, markets, scenarios and available data. We agree a timescale when we scope the project.”","sourceIds":["source-51046b84b97e8abe"]},{"id":"content-native-digital-agencies-12f6a9202d9259db-a-2e38eed3d39dedd7e4a1","label":"What access do we get to the model?","value":"“You receive access to view and explore the project simulations in SyMAP. Editing and rerunning those models requires a subsequent platform licence.”","sourceIds":["source-51046b84b97e8abe"]},{"id":"content-native-digital-agencies-12f6a9202d9259db-a-c2a3f7ceff8023bfa2e1","label":"Can you use our existing data?","value":"“Yes. We can start with your price files, forecasts and assumptions, or source and build reference data. The inputs remain visible in the analysis.”","sourceIds":["source-51046b84b97e8abe"]},{"id":"content-native-digital-agencies-12f6a9202d9259db-a-937405faa7dd9ca2c4dc","label":"Can you review analysis we already have?","value":"“Yes. We can independently rebuild an analysis to investigate differences between models or check a result before it reaches a decision-making meeting.”","sourceIds":["source-51046b84b97e8abe"]},{"id":"content-native-digital-agencies-12f6a9202d9259db-a-33de609b9a032870998c","label":"Pharmaceutical pricing projects and consulting","value":"“Expert-led MFN assessments, international reference pricing analysis and launch strategy delivered in SyMAP.”","sourceIds":["source-51046b84b97e8abe"]}],"knowledge":{"offerings":[{"id":"content-native-digital-agencies-12f6a9202d9259db-offering-33de609b9a032870998c","name":"Pharmaceutical pricing projects and consulting","description":"“Expert-led MFN assessments, international reference pricing analysis and launch strategy delivered in SyMAP.”","url":"https://symaptics.com/services/","claimIds":["content-native-digital-agencies-12f6a9202d9259db-a-33de609b9a032870998c"],"sourceIds":["source-51046b84b97e8abe"]}],"answers":[{"id":"content-native-digital-agencies-12f6a9202d9259db-a-4b975b07e2a09adeb35e","question":"Do we need a SyMAP licence?","answer":"“No. You can commission a project on its own. A licence is optional if you want your team to edit and rerun models afterwards.”","sourceIds":["source-51046b84b97e8abe"],"claimIds":["content-native-digital-agencies-12f6a9202d9259db-a-4b975b07e2a09adeb35e"]},{"id":"content-native-digital-agencies-12f6a9202d9259db-a-4b162458202451775303","question":"How long does a project take?","answer":"“Timing depends on the portfolio, markets, scenarios and available data. We agree a timescale when we scope the project.”","sourceIds":["source-51046b84b97e8abe"],"claimIds":["content-native-digital-agencies-12f6a9202d9259db-a-4b162458202451775303"]},{"id":"content-native-digital-agencies-12f6a9202d9259db-a-2e38eed3d39dedd7e4a1","question":"What access do we get to the model?","answer":"“You receive access to view and explore the project simulations in SyMAP. Editing and rerunning those models requires a subsequent platform licence.”","sourceIds":["source-51046b84b97e8abe"],"claimIds":["content-native-digital-agencies-12f6a9202d9259db-a-2e38eed3d39dedd7e4a1"]},{"id":"content-native-digital-agencies-12f6a9202d9259db-a-c2a3f7ceff8023bfa2e1","question":"Can you use our existing data?","answer":"“Yes. We can start with your price files, forecasts and assumptions, or source and build reference data. The inputs remain visible in the analysis.”","sourceIds":["source-51046b84b97e8abe"],"claimIds":["content-native-digital-agencies-12f6a9202d9259db-a-c2a3f7ceff8023bfa2e1"]},{"id":"content-native-digital-agencies-12f6a9202d9259db-a-937405faa7dd9ca2c4dc","question":"Can you review analysis we already have?","answer":"“Yes. We can independently rebuild an analysis to investigate differences between models or check a result before it reaches a decision-making meeting.”","sourceIds":["source-51046b84b97e8abe"],"claimIds":["content-native-digital-agencies-12f6a9202d9259db-a-937405faa7dd9ca2c4dc"]}],"developments":[]},"sources":[{"id":"source-record","title":"Symaptics website","publisher":"symaptics.com","url":"https://symaptics.com/","accessedOn":"2026-10-20","relatedPublicationsUrl":"https://readyscan.ai/sources/source-12f6a9202d9259db"},{"id":"source-51046b84b97e8abe","title":"symaptics.com/services/","publisher":"symaptics.com","url":"https://symaptics.com/services/","accessedOn":"2026-10-20","relatedPublicationsUrl":"https://readyscan.ai/sources/source-51046b84b97e8abe"}],"ownership":{"state":"public_sourced_unclaimed","notice":"Public-source record; owner verification is not claimed.","provenance":{"snapshotId":"symaptics-q140724419-content-950b7c352e977164-snapshot","sourceId":"ready-scan-subjects","sourceRecordId":"Q140724419","sourceRevisionId":"Q140724419:content:bf94611725b17788","sourceContentHash":"fnv1a64:2feb348eadc3a757","recordRevisionId":"Q140724419:content:bf94611725b17788","recordContentHash":"fnv1a64:9307a3e3800662cf","sourceCanonicalUrl":"https://symaptics.com/","sourceModifiedAt":"2026-10-20T06:51:04.756Z","observedOn":"2026-10-20","permission":{"basis":"public_information","evidenceUrl":"https://symaptics.com/"},"attributionUrl":"https://symaptics.com/"}},"datePublished":"2026-10-20","dateModified":"2026-10-20","contentFingerprint":"fnv1a64:a309a7be66ad5efa","revision":"fnv1a64:4b01929db5101198","agentProtocol":{"discovery":"https://readyscan.ai/api/v1/ai-search/discovery","evidence":"https://readyscan.ai/api/v1/ai-search/entities/symaptics-q140724419/evidence"},"structuredData":{"@context":"https://schema.org","@id":"https://directory.readyscan.ai/entities/symaptics-q140724419#entity","name":"Symaptics","identifier":"urn:readyscan:entity:symaptics-q140724419","description":"Symaptics: “Symaptics builds SyMAP, a pharmaceutical pricing and market access platform covering international reference pricing simulation, US Most Favored Nation policy modelling, and global revenue forecasting and optimisation. London based, founded by pharmaceutical pricing specialists.”","url":"https://symaptics.com/","mainEntityOfPage":"https://directory.readyscan.ai/entities/symaptics-q140724419","datePublished":"2026-10-20","dateModified":"2026-10-20","citation":["https://symaptics.com/","https://symaptics.com/services/"],"additionalProperty":[{"@type":"PropertyValue","propertyID":"ownership-state","name":"Ownership state","value":"public_sourced_unclaimed"},{"@type":"PropertyValue","propertyID":"content-fingerprint","name":"Material content fingerprint","value":"fnv1a64:a309a7be66ad5efa"},{"@type":"PropertyValue","propertyID":"source-record","name":"Source record","value":"ready-scan-subjects/Q140724419"},{"@type":"PropertyValue","propertyID":"source-revision","name":"Source revision","value":"Q140724419:content:bf94611725b17788"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-12f6a9202d9259db-a-603be0e3bf5c7b2a558f","name":"Symaptics","value":"“Symaptics builds SyMAP, a pharmaceutical pricing and market access platform covering international reference pricing simulation, US Most Favored Nation policy modelling, and global revenue forecasting and optimisation. London based, founded by pharmaceutical pricing specialists.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-12f6a9202d9259db-a-4b975b07e2a09adeb35e","name":"Do we need a SyMAP licence?","value":"“No. You can commission a project on its own. A licence is optional if you want your team to edit and rerun models afterwards.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-12f6a9202d9259db-a-4b162458202451775303","name":"How long does a project take?","value":"“Timing depends on the portfolio, markets, scenarios and available data. We agree a timescale when we scope the project.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-12f6a9202d9259db-a-2e38eed3d39dedd7e4a1","name":"What access do we get to the model?","value":"“You receive access to view and explore the project simulations in SyMAP. Editing and rerunning those models requires a subsequent platform licence.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-12f6a9202d9259db-a-c2a3f7ceff8023bfa2e1","name":"Can you use our existing data?","value":"“Yes. We can start with your price files, forecasts and assumptions, or source and build reference data. The inputs remain visible in the analysis.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-12f6a9202d9259db-a-937405faa7dd9ca2c4dc","name":"Can you review analysis we already have?","value":"“Yes. We can independently rebuild an analysis to investigate differences between models or check a result before it reaches a decision-making meeting.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-12f6a9202d9259db-a-33de609b9a032870998c","name":"Pharmaceutical pricing projects and consulting","value":"“Expert-led MFN assessments, international reference pricing analysis and launch strategy delivered in SyMAP.”"}],"@type":"Organization"}}